Frontlight ResearchEarly access
Spinal muscular atrophy trials in China
2 of 10 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationA Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA
- Where
- Shanghai
- Age
- 1 month and over
- People
- 18
- Run by
- Guangzhou Jiayin Biotech Ltd
See details and how to joinNCT06588803 - No phaseTaking peopleA Registered Cohort Study on SMA
- Where
- Fuzhou
- Age
- 1 week to 70 years
- People
- 2,000
- Run by
- Wan-Jin Chen
See details and how to joinNCT04010604